These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
427 related items for PubMed ID: 9725227
1. A plasmid encoding murine granulocyte-macrophage colony-stimulating factor increases protection conferred by a malaria DNA vaccine. Weiss WR, Ishii KJ, Hedstrom RC, Sedegah M, Ichino M, Barnhart K, Klinman DM, Hoffman SL. J Immunol; 1998 Sep 01; 161(5):2325-32. PubMed ID: 9725227 [Abstract] [Full Text] [Related]
2. Can malaria DNA vaccines on their own be as immunogenic and protective as prime-boost approaches to immunization? Hoffman SL, Doolan DL. Dev Biol (Basel); 2000 Sep 01; 104():121-32. PubMed ID: 11713810 [Abstract] [Full Text] [Related]
3. Immunological responses of neonates and infants to DNA vaccines. Sedegah M, Hoffman SL. Methods Mol Med; 2006 Sep 01; 127():239-51. PubMed ID: 16988458 [Abstract] [Full Text] [Related]
4. Intramuscular immunization with a monogenic plasmid DNA tuberculosis vaccine: Enhanced immunogenicity by electroporation and co-expression of GM-CSF transgene. Zhang X, Divangahi M, Ngai P, Santosuosso M, Millar J, Zganiacz A, Wang J, Bramson J, Xing Z. Vaccine; 2007 Jan 26; 25(7):1342-52. PubMed ID: 17052817 [Abstract] [Full Text] [Related]
5. Improving protective immunity induced by DNA-based immunization: priming with antigen and GM-CSF-encoding plasmid DNA and boosting with antigen-expressing recombinant poxvirus. Sedegah M, Weiss W, Sacci JB, Charoenvit Y, Hedstrom R, Gowda K, Majam VF, Tine J, Kumar S, Hobart P, Hoffman SL. J Immunol; 2000 Jun 01; 164(11):5905-12. PubMed ID: 10820272 [Abstract] [Full Text] [Related]
6. Plasmodium: mammalian codon optimization of malaria plasmid DNA vaccines enhances antibody responses but not T cell responses nor protective immunity. Dobaño C, Sedegah M, Rogers WO, Kumar S, Zheng H, Hoffman SL, Doolan DL. Exp Parasitol; 2009 Jun 01; 122(2):112-23. PubMed ID: 19249301 [Abstract] [Full Text] [Related]
7. Targeting antigen to MHC Class I and Class II antigen presentation pathways for malaria DNA vaccines. Dobaño C, Rogers WO, Gowda K, Doolan DL. Immunol Lett; 2007 Aug 15; 111(2):92-102. PubMed ID: 17604849 [Abstract] [Full Text] [Related]
8. Genetically attenuated parasite vaccines induce contact-dependent CD8+ T cell killing of Plasmodium yoelii liver stage-infected hepatocytes. Trimnell A, Takagi A, Gupta M, Richie TL, Kappe SH, Wang R. J Immunol; 2009 Nov 01; 183(9):5870-8. PubMed ID: 19812194 [Abstract] [Full Text] [Related]
9. Persistence of protective immunity to malaria induced by DNA priming and poxvirus boosting: characterization of effector and memory CD8(+)-T-cell populations. Sedegah M, Brice GT, Rogers WO, Doolan DL, Charoenvit Y, Jones TR, Majam VF, Belmonte A, Lu M, Belmonte M, Carucci DJ, Hoffman SL. Infect Immun; 2002 Jul 01; 70(7):3493-9. PubMed ID: 12065488 [Abstract] [Full Text] [Related]
10. Further analysis of protection induced by the MIC3 DNA vaccine against T. gondii: CD4 and CD8 T cells are the major effectors of the MIC3 DNA vaccine-induced protection, both Lectin-like and EGF-like domains of MIC3 conferred protection. Ismael AB, Hedhli D, Cérède O, Lebrun M, Dimier-Poisson I, Mévélec MN. Vaccine; 2009 May 14; 27(22):2959-66. PubMed ID: 19428907 [Abstract] [Full Text] [Related]
11. IL-12 and NK cells are required for antigen-specific adaptive immunity against malaria initiated by CD8+ T cells in the Plasmodium yoelii model. Doolan DL, Hoffman SL. J Immunol; 1999 Jul 15; 163(2):884-92. PubMed ID: 10395683 [Abstract] [Full Text] [Related]
12. Protection against malaria by Plasmodium yoelii sporozoite surface protein 2 linear peptide induction of CD4+ T cell- and IFN-gamma-dependent elimination of infected hepatocytes. Wang R, Charoenvit Y, Corradin G, De La Vega P, Franke ED, Hoffman SL. J Immunol; 1996 Nov 01; 157(9):4061-7. PubMed ID: 8892640 [Abstract] [Full Text] [Related]
13. Coexpression of Flt3 ligand and GM-CSF genes modulates immune responses induced by HER2/neu DNA vaccine. Yo YT, Hsu KF, Shieh GS, Lo CW, Chang CC, Wu CL, Shiau AL. Cancer Gene Ther; 2007 Nov 01; 14(11):904-17. PubMed ID: 17704754 [Abstract] [Full Text] [Related]
14. Cytokine-facilitated priming of CD8+ T cell responses by DNA vaccination. Kwissa M, Kröger A, Hauser H, Reimann J, Schirmbeck R. J Mol Med (Berl); 2003 Feb 01; 81(2):91-101. PubMed ID: 12601525 [Abstract] [Full Text] [Related]
15. Boosting of DNA vaccine-elicited gamma interferon responses in humans by exposure to malaria parasites. Wang R, Richie TL, Baraceros MF, Rahardjo N, Gay T, Banania JG, Charoenvit Y, Epstein JE, Luke T, Freilich DA, Norman J, Hoffman SL. Infect Immun; 2005 May 01; 73(5):2863-72. PubMed ID: 15845492 [Abstract] [Full Text] [Related]
16. Induction of protective polyclonal antibodies by immunization with a Plasmodium yoelii circumsporozoite protein multiple antigen peptide vaccine. Wang R, Charoenvit Y, Corradin G, Porrozzi R, Hunter RL, Glenn G, Alving CR, Church P, Hoffman SL. J Immunol; 1995 Mar 15; 154(6):2784-93. PubMed ID: 7876549 [Abstract] [Full Text] [Related]
17. Delivery of multiple CD8 cytotoxic T cell epitopes by DNA vaccination. Thomson SA, Sherritt MA, Medveczky J, Elliott SL, Moss DJ, Fernando GJ, Brown LE, Suhrbier A. J Immunol; 1998 Feb 15; 160(4):1717-23. PubMed ID: 9469429 [Abstract] [Full Text] [Related]
18. Effect on antibody and T-cell responses of mixing five GMP-produced DNA plasmids and administration with plasmid expressing GM-CSF. Sedegah M, Charoenvit Y, Aguiar J, Sacci J, Hedstrom R, Kumar S, Belmonte A, Lanar DE, Jones TR, Abot E, Druilhe P, Corradin G, Epstein JE, Richie TL, Carucci DJ, Hoffman SL. Genes Immun; 2004 Nov 15; 5(7):553-61. PubMed ID: 15318164 [Abstract] [Full Text] [Related]
19. Intranasal immunization of a DNA vaccine with IL-12- and granulocyte-macrophage colony-stimulating factor (GM-CSF)-expressing plasmids in liposomes induces strong mucosal and cell-mediated immune responses against HIV-1 antigens. Okada E, Sasaki S, Ishii N, Aoki I, Yasuda T, Nishioka K, Fukushima J, Miyazaki J, Wahren B, Okuda K. J Immunol; 1997 Oct 01; 159(7):3638-47. PubMed ID: 9317164 [Abstract] [Full Text] [Related]
20. Cytokine-in-adjuvant steering of the immune response phenotype to HIV-1 vaccine constructs: granulocyte-macrophage colony-stimulating factor and TNF-alpha synergize with IL-12 to enhance induction of cytotoxic T lymphocytes. Ahlers JD, Dunlop N, Alling DW, Nara PL, Berzofsky JA. J Immunol; 1997 Apr 15; 158(8):3947-58. PubMed ID: 9103465 [Abstract] [Full Text] [Related] Page: [Next] [New Search]